How pharmaceutical messaging affects opioid use among U.S. military veterans
The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans
['FUNDING_R01'] · NDRI-USA, INC. · NIH-11032039
This study looks at how the pharmaceutical industry has affected the way military veterans use opioids, aiming to understand the messages they've received about these medications and how that might have made it harder for them to explore other pain relief options.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NDRI-USA, INC. (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11032039 on ClinicalTrials.gov |
What this research studies
This research investigates how the pharmaceutical industry has influenced opioid consumption among military veterans, a group particularly vulnerable to opioid-related issues. By analyzing various textual data and employing innovative data mining techniques, the project aims to uncover the narratives promoted by the industry that have shaped veterans' perceptions of opioid therapies. The study will also explore how these narratives have created barriers to alternative pain management options, ultimately affecting veterans' health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are military veterans who have been prescribed opioids or are experiencing chronic pain.
Not a fit: Patients who are not military veterans or those who do not have a history of opioid use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing opioid misuse and better pain management options for veterans.
How similar studies have performed: Previous research has shown that understanding the influence of pharmaceutical marketing can lead to significant improvements in public health strategies, indicating potential success for this approach.
Where this research is happening
NEW YORK, UNITED STATES
- NDRI-USA, INC. — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HADDOCK, CHRISTOPHER KEITH — NDRI-USA, INC.
- Study coordinator: HADDOCK, CHRISTOPHER KEITH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anxiety Disorders